Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Molecular Pathway Leads to Skin and Hair Regeneration After Injury

By LabMedica International staff writers
Posted on 25 Aug 2015
The ability of the skin to regenerate after injury has been linked to stimulation of Toll-Like Receptor 3 (TLR3) by double-stranded RNA (dsRNA) released by the damaged skin.

Replacement of skin and hair follicles after wounding through a process known as wound-induced hair neogenesis (WIHN) is a rare example of adult organ regeneration in mammals. More...
As such, WIHN provides a unique model system for deciphering mechanisms underlying mammalian regeneration.

Investigators at Johns Hopkins University (Baltimore, MD, USA) used mouse models to study skin and hair follicle regeneration. Initially, by comparing normal mice to an inbred strain with restricted ability to regenerate skin, they found that expression of TLR3 was three times higher in the normal animals.

The application of synthetic dsRNA to mouse skin wounds led to a greater number of regenerated follicles. In contrast, treatment with a substance that broke up dsRNA decreased the number of regenerated follicles, and regeneration was nearly abolished in mice deficient in TLR3.

Results published in the August 6, 2015, issue of the journal Cell Stem Cell revealed that the process that began with dsRNA activation of TLR3 continued to hair follicle regeneration through the action of TLR3's downstream effectors IL-6 (interleukin-6) and STAT3 (signal transducer and activator of transcription 3). Loss of TLR3, IL-6Ra, or Stat3 proteins reduced WHIN in mice with damaged skin.

“Our study uncovers a novel role for a protein that works as a master regulator of regeneration in the skin,” said senior author Dr. Luis A. Garza, associate professor of dermatology at Johns Hopkins University. “Medications that turn on this protein have the powerful potential to decrease scarring as healing of wounds takes place, thereby promoting skin and hair follicle regeneration.”

“A lot of human disability is from scarring,” said Dr. Garza. “After a heart attack, we are really good at replacing the blood flow, but it is the scar on the heart afterward that is the real problem. We and others in the field of regenerative medicine are interested in how to enhance or trigger regeneration in such situations.”

Related Links:
Johns Hopkins University



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.